IceBath: NOICE vs Nothing
NOICE-Icebath
NOICE: A Prospective, Randomized, Crossover Study (NOICE vs. Nothing)
1 other identifier
interventional
42
1 country
1
Brief Summary
This prospective, randomized, 2-period crossover study seeks to evaluate the effect of the non-visual immersive technology-based audio biofeedback intervention, delivered through devices such as NOICE device or Quest 3, on cold pain threshold within participants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable pain
Started Mar 2026
Shorter than P25 for not_applicable pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 5, 2025
CompletedFirst Posted
Study publicly available on registry
November 12, 2025
CompletedStudy Start
First participant enrolled
March 10, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 2, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 2, 2026
CompletedMay 18, 2026
May 1, 2026
23 days
November 5, 2025
May 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain score
Pain sensitivity will be measured by Numerical Rating Pain Scale. Participants will rank pain scores on a sliding scale from 0 = No Pain to 10 = Worst possible pain
Immediately after intervention
Secondary Outcomes (5)
Anxiety Level
Immediately after intervention
Cold pain endurance
Periprocedural
ISO Ergonomic scale
immediately after intervention
System Usability Scale (SUS) Score
immediately after intervention
Device satisfaction
immediately after intervention
Study Arms (4)
Group 1
EXPERIMENTALParticipants first perform the task with non-visual immersive technology-based audio biofeedback using the dominant hand, followed by without non-visual immersive technology-based audio biofeedback using the non-dominant hand.
Group 2
EXPERIMENTALParticipants first perform the task with non-visual immersive technology-based audio biofeedback using the non-dominant hand, followed by without non-visual immersive technology-based audio biofeedback using the dominant hand.
Group 3
EXPERIMENTALParticipants first perform the task without non-visual immersive technology-based audio biofeedback using the dominant hand, followed by with non-visual immersive technology-based audio biofeedback using the non-dominant hand.
Group 4
EXPERIMENTALParticipants first perform the task without non-visual immersive technology-based audio biofeedback using the non-dominant hand, followed by with non-visual immersive technology-based audio biofeedback using the dominant hand.
Interventions
Participants complete the same cold pain endurance tasks without any non-visual immersive technology-based auditory feedback.
Participants receive real-time auditory feedback during cold pain endurance tasks.
Eligibility Criteria
You may qualify if:
- Ages 18 years and older
- English-speaking
- Intact hearing
- No self-reported or clinically diagnosed acute or chronic medical conditions that may affect safe participation
You may not qualify if:
- Use chronotropic heart medications
- Use pain medications
- Current hearing loss
- Currently taking beta blockers, or opioids or other prescription pain medications
- History of chronic pain or acute pain syndromes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Lucile Packard Childrens Hospital Stanford
Palo Alto, California, 94304, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
November 5, 2025
First Posted
November 12, 2025
Study Start
March 10, 2026
Primary Completion
April 2, 2026
Study Completion
April 2, 2026
Last Updated
May 18, 2026
Record last verified: 2026-05